Diagnose Fault Of Computer System and Networks

4th_QTR_Module2_Pre-Test_Module 2 Diagnose Fault of Computer Systems and Networks

Review Pass Lesson: Module 2_ Diagnose Fault of Computer Systems and Networks

1) Which of the following is NOT one of the classifications indicating the source of a drug? A) Genetically engineered B) Chemically altered C) Natural D) Synthetic 2) Acetylsalicylic acid, also known as aspirin, is derived from a(n) source. A) animal B) mineral C) synthetic 3) Which of the following is derived from an animal source? A) Thyroid hormone B) Vincristine C) Digoxin D) Codeine 1) 2) 3) 4) What mineral is used to treat arthritis? A) Zinc C) Ferrous sulfate B) Sodium chloride D) Gold 4) 5) A naturally occurring substance that has been chemically altered is considered a drug. 5) A) genetically engineered B) aemi-synthetic C) synthesized D) hazardous 6) A drug that is produced in a laboratory in imitations of a naturally occurring compound is called: 6) A) Genetically engineered. B) Synthesized. C) Semi-synthetic. D) Bioenhanced. 7) Which of the following is an example of a synthetic drug? A) Sodium chloride B) Digoxin C) Barbiturates D) Insulin 7) 8) To create a genetically engineered drug, manufactures use DNA, combining two different 8) strands of DNA to produce a new strand. A) recombined B) reconciled D) recombinant 9) Genetically engineered drugs include rDNA and , hybrid cells created in the laboratory 9) from animals and used to treat tumors and diagnose various conditions. A) recombinant antibodies B) oumoclnnal antibodies C) mononucleotides D) semi-synthetic penicillins 10) Characterisfics of a drug's chemical name include the following EXCEPT: A) Chosen according to IUPAC guidelines. B) Long, complicated, hard to remember and pronounce. C) Proprietary name that only the manufacturer is allowed to use. D) Used primarily in chemistry and pharmacy research.

Diagnos och utvärdering - Starter Quiz

Disorders, Diagnoses, Defintions Readings

Policy for Bloodborne Pathogen Exposure Incident as per OSHA regulation (29 CFR 1910.1030) Purpose: To ensure that ASC staff members are protected against potential exposure to bloodborne pathogens per OSHA regulations (29 CFR 1910.1030). Scope: This policy applies to all ASC staff members who may be exposed to blood or other potentially infectious materials during their duties. Policy: An exposure incident is defined as a specific eye, mouth, other mucous membranes, non-intact skin, or parenteral contact with blood or other potentially infectious materials that results from the performance of an employee's duties. Any spill or accident that results in an exposure incident must be immediately reported to the Infection Control Nurse, first-line leader, or another responsible person. The employer shall make available the hepatitis B vaccine and vaccination series to all employees who have occupational exposure and post-exposure evaluation and follow-up to all employees who have had an exposure incident. The employer shall provide a confidential medical evaluation and follow-up for the exposed employee, which shall include at least the following elements: • Documentation of the route(s) of exposure and the circumstances under which the exposure incident occurred. • Identification and documentation of the source individual, unless the employer can establish that identification is infeasible or prohibited by state or local law. The source individual's blood shall be tested as soon as feasible and after consent is obtained to determine HBV and HIV infectivity. • Collection and testing of blood for HBV and HIV serological status. • If the employee consents to baseline blood collection but does not consent to HIV serologic testing, the sample shall be preserved for at least 90 days. If, within 90 days of the exposure incident, the employee elects to have the baseline sample tested, such testing shall be done as soon as feasible • Post-exposure prophylaxis, when medically indicated, as recommended by the U.S. Public Health Service. • Counseling. • Evaluation of reported illnesses. The employer shall ensure that the healthcare professional evaluating an employee after an exposure incident is provided with the following: A copy of OSHA regulation 1910.1030 A description of the exposed employee's duties as they relate to the exposure incident Documentation of the route(s) of exposure and circumstances under which exposure occurred Results of the source individual's blood testing, if available. All medical records are relevant to the appropriate treatment of the employee, including vaccination status, which is the employer's responsibility to maintain. The employer shall obtain and provide the employee with a copy of the evaluating healthcare professional's written opinion within 15 days of the completion of the evaluation. The healthcare professional's written opinion for Hepatitis B vaccination shall include the following: Whether it is indicated for the employee If the employee has received such a vaccination The healthcare professional's written opinion for post-exposure evaluation and follow-up shall include the following: That the employee has been informed of the results of the evaluation That the employee has been told about any medical conditions resulting from exposure to blood or other potentially infectious materials which require further evaluation or treatment All other findings or diagnoses shall remain confidential and not be included in the written report. An employer must establish and maintain accurate medical records for each employee with occupational exposure. Records should include the employee's Name, hepatitis B vaccination status and dates, results of medical testing and follow-up procedures, healthcare professional's written opinion, and information provided to the healthcare professional. Records must be kept confidential and not disclosed without the employee's written consent, except as required by law. Records must be kept for at least the duration of the employee's employment plus 30 years. Form 7.041 Employee Consent Form for Testing for HBV and HIV Serological Status Following Accidental Exposure I, __________________________, understand that I have been involved in an accidental exposure incident and may be at risk for contracting Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV) under 29 CFR 1910.1030. Therefore, following OSHA standards, I am being offered the opportunity to be tested for these viruses. I understand that the testing will involve a blood sample and that the results will be kept confidential and will only be shared with authorized personnel. I also understand that testing is voluntary and that I have the right to refuse to test. By signing this form, I consent to be tested for HBV and HIV following the accidental exposure incident. Signed: __________________________ Patient's Name: __________________________ Form 7.042 Patient Consent Form for Testing for HBV and HIV Serological Status Following Accidental Exposure I, __________________________, understand that a staff member involved in an accidental exposure incident may be at risk for contracting Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV) following 29 CFR 1910.1030. Therefore, by OSHA standards, the staff member may be offered the opportunity to be tested for these viruses. I also understand that testing of my blood is necessary to determine if I am infected with HBV and HIV. The results will be kept confidential and only shared with authorized personnel. I understand that testing is voluntary and that I have the right to refuse to test. By signing this form, I consent to the staff member being tested for HBV and HIV and to my blood testing following the accidental exposure incident. Signed: __________________________ Form7.043 Refusal of Testing Patient/Employee (Circle One) I,_____________________________________, understand that I have the right to refuse testing for Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV) following an accidental exposure incident per 29 CFR 1910.1030. I understand that if I refuse to test, it may impact my ability to receive appropriate medical treatment and the healthcare facility's power to respond to the exposure incident. Following 29 CFR 1910.1030, The source individual's blood shall be tested as soon as feasible and after consent is obtained to determine HBV and HIV infectivity. The employer shall establish that legally required consent cannot be obtained if permission is not obtained. When the source individual's consent is not required by law, the source individual's blood, if available, shall be tested, and the results documented. Signed: __________________________

A1 Psychological definition of health and ill health, addiction and stress Definitions and characteristics of health and ill health, addiction and stress. Health and ill health: biomedical, biopsychosocial, health as a continuum. Behavioural and physiological addiction: o Griffiths’ six components of addiction: physical and psychological dependence (salience), tolerance, withdrawal, relapse, conflict, mood alteration o stress: definition of a stressor, psychological stress, stress and perceived ability to cope. A2 Psychological approaches to health Biological influences – of genetic predisposition, the roles of neurotransmitter imbalances. Behaviourist approaches – the role of cues, positive reinforcement and negative reinforcement to explain healthy and unhealthy behaviours; using operant conditioning to encourage and incentivise behaviour. Social learning approach – effects of parental and peer role models on healthy and unhealthy behaviours; role models in health education. • Cognitive approach – decisions to engage in behaviours to provide relief from stress, anxiety, boredom or to mitigate impacts of other health problems, resolving cognitive dissonance for behaviour change, professional biases in diagnoses and treatments. A3 Theories of stress, behavioural addiction and physiological addiction Theories: key concepts of psychological theories of stress, behavioural addiction and physiological addiction, to include: Health belief model concepts of perceived seriousness, susceptibility, cost-benefit analysis, how demographic variables such as age, gender, culture and external/internal cues affect behaviour Locus of control: internal and external locus of control, the role of attributions in determining health behaviour

Related quizzes

Related quizzes